1. ScholarBank@NUS

Lingzhi Wang

rp05443

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
Main Affiliation
 
Faculty
 
Email
csiwl@nus.edu.sg
 
Other emails
 

Publications

Results 21-40 of 75 (Search time: 0.016 seconds).

Issue DateTitleAuthor(s)
2113-Aug-2019Different treatment efficacies and side effects of cytotoxicchemotherapyWang Lingzhi ; Chong Qing Yun ; Goh Boon Cher ; Soo Ross ; Li Low-Jia
22Dec-2008Does saturable formation of gemcitabine triphosphate occur in patients?Tham, L.-S.; Wang, L.-Z. ; Soo, R.A. ; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.; Holford, N.H.G.
2328-Feb-2008Drying efficiency and particle movement in coating-Impact on particle agglomeration and yieldTang, E.S.K.; Wang, L. ; Liew, C.V. ; Chan, L.W. ; Heng, P.W.S. 
242001Effect of cetrimide and ascorbic acid on in vitro human skin permeation of haloperidolVaddi, H.K.; Wang, L.Z. ; Ho, P.C.-L. ; Chan, Y.W.; Chan, S.Y. 
2516-Jan-2001Effect of some enhancers on the permeation of haloperidol through rat skin in vitroVaddi, H.K.; Wang, L.Z. ; Ho, P.C. ; Chan, S.Y. 
2620-Nov-2006Effects of high dose of simvastatin on levels of dopamine and its reuptake in prefrontal cortex and striatum among SD ratsWang, Q.; Tang, X.N.; Wang, L. ; Yenari, M.A.; Ying, W.; Goh, B.-C.; Lee, H.-S.; Wilder-Smith, E.P.; Wong, P.T.
2727-Sep-2021Epigenetic derepression converts PPAR gamma into a druggable target in triple-negative and endocrine-resistant breast cancersLoo, Ser Yue; Syn, Nicholas L; Koh, Angele Pei-Fern ; Teng, Janet Cheng-Fei ; Deivasigamani, Amudha; Tan, Tuan Zea ; Thike, Aye Aye ; Vali, Shireen ; Kapoor, Shweta; Wang, Xiaoyuan ; Wang, Jiong Wei ; Tan, Puay Hoon ; Yip, George W ; Sethi, Gautam ; Huang, Ruby Yun-Ju ; Hui, Kam Man ; Wang, Lingzhi ; Goh, Boon Cher ; Kumar, Alan Prem 
2820-Sep-2012Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research groupYeo, W.; Chung, H.C.; Chan, S.L.; Wang, L.Z. ; Lim, R.; Picus, J.; Boyer, M.; Mo, F.K.F.; Koh, J.; Rha, S.Y.; Hui, E.P.; Jeung, H.C.; Roh, J.K.; Yu, S.C.H.; To, K.F.; Tao, Q.; Ma, B.B.; Chan, A.W.H.; Tong, J.H.M.; Erlichman, C.; Chan, A.T.C.; Goh, B.C.
291-Sep-2002Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategiesGoh, B.-C.; Lee, S.-C. ; Wang, L.-Z. ; Fan, L.; Guo, J.-Y. ; Lamba, J.; Schuetz, E.; Lim, R.; Lim, H.-L.; Ong, A.-B.; Lee, H.-S.
301-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
3117-Jun-2019FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling PathwayWang Lingzhi 
32Jul-2013Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTan, T.Z.; Miow, Q.H.; Huang, R.Y.-J.; Wong, M.K.; Ye, J.; Lau, J.A.; Wu, M.C. ; Bin Abdul Hadi, L.H.; Soong, R. ; Choolani, M.; Davidson, B.; Nesland, J.M.; Wang, L.-Z. ; Matsumura, N.; Mandai, M.; Konishi, I.; Goh, B.-C.; Chang, J.T.; Thiery, J.P. ; Mori, S. 
332015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
3430-Jan-2013Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer PatientsWang, L.-Z. ; Ramírez, J.; Yeo, W.; Chan, M.-Y.M.; Thuya, W.-L. ; Lau, J.-Y.A.; Wan, S.-C.; Wong, A.L.-A.; Zee, Y.-K.; Lim, R.; Lee, S.-C. ; Ho, P.C. ; Lee, H.-S.; Chan, A.; Ansher, S.; Ratain, M.J.; Goh, B.-C.
353-Aug-2012Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKLWen, Q.; Goldenson, B.; Silver, S.J.; Schenone, M.; Dancik, V.; Huang, Z.; Wang, L.-Z. ; Lewis, T.A.; An, W.F.; Li, X.; Bray, M.-A.; Thiollier, C.; Diebold, L.; Gilles, L.; Vokes, M.S.; Moore, C.B.; Bliss-Moreau, M.; Verplank, L.; Tolliday, N.J.; Mishra, R.; Vemula, S.; Shi, J.; Wei, L.; Kapur, R.; Lopez, C.K.; Gerby, B.; Ballerini, P.; Pflumio, F.; Gilliland, D.G.; Goldberg, L.; Birger, Y.; Izraeli, S.; Gamis, A.S.; Smith, F.O.; Woods, W.G.; Taub, J.; Scherer, C.A.; Bradner, J.E.; Goh, B.-C.; Mercher, T.; Carpenter, A.E.; Gould, R.J.; Clemons, P.A.; Carr, S.A.; Root, D.E.; Schreiber, S.L.; Stern, A.M.; Crispino, J.D.
362019Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal TransitionCheng, J.-T.; Wang, L. ; Wang, H. ; Tang, F.-R. ; Cai, W.-Q.; Sethi, G. ; Xin, H.-W.; Ma, Z.
3714-Aug-2020Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.Chong, Wan Qin; Lim, Chwee Ming ; Sinha, Arvind Kumar ; Tan, Chee Seng ; Chan, Gloria Hui Jia; Huang, Yiqing; Barr Kumarakulasinghe, Nesaretnam; Sundar, Raghav ; Jeyasekharan, Anand D ; Loh, Woei Shyang ; Tay, Joshua K. ; Yadav, Kritika ; Wang, Lingzhi ; Wong, Andrea L. ; Kong, Li Ren ; Soo, Ross Andrew ; Lau, Jieying Amelia ; Soon, Yu Yang ; Goh, Robby Miguel; Ho, Francis Cho Hao ; Chong, Siew Meng ; Lee, Soo-Chin ; Loh, Kwok Seng ; Tai, Bee Choo ; Lim, Yaw Chyn ; Goh, Boon Cher 
18Apr-2006Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drugTham, L.-S.; Lee, H.-S.; Wang, L. ; Yong, W.-P. ; Fan, L.; Ong, A.-B.; Sukri, N.; Soo, R. ; Lee, S.-C. ; Goh, B.-C.
191-Dec-2007Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4α, and constitutive androstane receptor with docetaxel pharmacokineticsTham, L.-S.; Holford, N.H.G.; Hor, S.-Y.; Tan, T. ; Wang, L. ; Lim, R.-C.; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.
205-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo